BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 24612353)

  • 21. Impact of concordant and discordant bone marrow involvement on outcome in diffuse large B-cell lymphoma treated with R-CHOP.
    Sehn LH; Scott DW; Chhanabhai M; Berry B; Ruskova A; Berkahn L; Connors JM; Gascoyne RD
    J Clin Oncol; 2011 Apr; 29(11):1452-7. PubMed ID: 21383296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful treatment of intravascular large B-cell lymphoma diagnosed by bone marrow biopsy and FDG-PET scan.
    Takahashi T; Minato M; Tsukuda H; Yoshimoto M; Tsujisaki M
    Intern Med; 2008; 47(10):975-9. PubMed ID: 18480585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary bone lymphoma involving bilateral tibia.
    Giardino AA; Shinagare AB; Shinagare SA; Dewar R; Weckstein D; Mauch P; Ramaiya NH; Freedman AS
    Am J Hematol; 2012 Sep; 87(9):924-5. PubMed ID: 22641233
    [No Abstract]   [Full Text] [Related]  

  • 24. Long-term remission of paroxysmal nocturnal hemoglobinuria following chemoimmunotherapy for non-Hodgkin lymphoma.
    Lai S; Venugopal P; Leslie W
    Clin Adv Hematol Oncol; 2012 Feb; 10(2):134-6. PubMed ID: 22402359
    [No Abstract]   [Full Text] [Related]  

  • 25. Intravascular large B-cell lymphoma diagnosed by FDG-PET/CT and endometrial biopsy.
    Takeoka Y; Inaba A; Fujitani Y; Kosaka S; Yamamura R; Senzaki H; Okamura T; Ohta K
    Rinsho Ketsueki; 2011 Nov; 52(11):1777-81. PubMed ID: 22185801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary Lymphoma of Liver-a Rare Space-Occupying Lesion.
    Patkar S; Dutt K; Shah A; Sengar M; Goel M
    J Gastrointest Cancer; 2020 Sep; 51(3):1057-1060. PubMed ID: 32333249
    [No Abstract]   [Full Text] [Related]  

  • 27. Transformed Waldenström macroglobulinaemia: clinical presentation and outcome. A multi-institutional retrospective study of 77 cases from the French Innovative Leukemia Organization (FILO).
    Durot E; Tomowiak C; Michallet AS; Dupuis J; Hivert B; Leprêtre S; Toussaint E; Godet S; Merabet F; Van Den Neste E; Ivanoff S; Roussel X; Zini JM; Regny C; Lemal R; Sutton L; Perrot A; Le Dû K; Kanagaratnam L; Morel P; Leblond V; Delmer A
    Br J Haematol; 2017 Nov; 179(3):439-448. PubMed ID: 28770576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary large B-cell lymphoma of the bone marrow.
    Hishizawa M; Okamoto K; Chonabayashi K; Kaneko H; Watanabe M; Tsudo M
    Br J Haematol; 2007 Feb; 136(3):351. PubMed ID: 17233843
    [No Abstract]   [Full Text] [Related]  

  • 29. Combined treatment with rituximab and anthracycline-containing chemotherapy for primary cutaneous large B-cell lymphomas, leg type, in elderly patients.
    Guyot A; Ortonne N; Valeyrie-Allanore L; Bagot M
    Arch Dermatol; 2010 Jan; 146(1):89-91. PubMed ID: 20083704
    [No Abstract]   [Full Text] [Related]  

  • 30. Utility of interim and end-of-treatment [(18)F]-fluorodeoxyglucose positron emission tomography-computed tomography in frontline therapy of patients with diffuse large B-cell lymphoma.
    Huntington SF; Nasta SD; Schuster SJ; Doshi JA; Svoboda J
    Leuk Lymphoma; 2015; 56(9):2579-84. PubMed ID: 25629993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-risk diffuse large B-cell lymphoma: can we do better than rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone?
    George A; Tam CS; Seymour JF
    Leuk Lymphoma; 2013 Dec; 54(12):2575-6. PubMed ID: 23597141
    [No Abstract]   [Full Text] [Related]  

  • 32. R2-CHOP vs R-CHOP for diffuse large B-cell lymphoma.
    Fowler NH
    Clin Adv Hematol Oncol; 2014 Sep; 12(9):608-10. PubMed ID: 25654483
    [No Abstract]   [Full Text] [Related]  

  • 33. Primary bone marrow diffuse large B cell lymphoma: a case series and review.
    Chang H; Hung YS; Lin TL; Wang PN; Kuo MC; Tang TC; Wu JH; Dunn P; Shih LY
    Ann Hematol; 2011 Jul; 90(7):791-6. PubMed ID: 21181164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary Mediastinal Large B-Cell Lymphoma As an Incidental Finding: Report of a Case.
    Yönal-Hindilerden İ; Hindilerden F; Arslan S; Doğan İÖ; Nalçacı M
    Turk J Haematol; 2018 May; 35(2):141-142. PubMed ID: 27094863
    [No Abstract]   [Full Text] [Related]  

  • 35. Bortezomib in combination with infusional dose-adjusted EPOCH for the treatment of plasmablastic lymphoma.
    Castillo JJ; Reagan JL; Sikov WM; Winer ES
    Br J Haematol; 2015 May; 169(3):352-5. PubMed ID: 25612847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone Marrow Involvement of Epstein-Barr Virus-Positive Large B-Cell Lymphoma in a Patient with Angioimmunoblastic T-Cell Lymphoma.
    Lee T; Park BG; You E; Cho YU; Jang S; Lee SM; Suh C; Park CJ
    Ann Lab Med; 2018 Mar; 38(2):172-175. PubMed ID: 29214764
    [No Abstract]   [Full Text] [Related]  

  • 37. Isolated central nervous system relapse in a patient with systemic diffuse large B-cell lymphoma: Diagnostic and treatment challenges.
    Das P; Dubashi B; Joseph D; Jain A
    Indian J Cancer; 2014; 51(4):468-9. PubMed ID: 26842164
    [No Abstract]   [Full Text] [Related]  

  • 38. Primary Cardiac Lymphoma in an Immunocompetent 71-Year-Old Man.
    Montanaro C; Loiacono F; Fragasso G; De Cobelli F; Foppoli M; Margonato A
    Tex Heart Inst J; 2015 Dec; 42(6):561-4. PubMed ID: 26664312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Double-hit diffuse large B-cell lymphoma.
    Friedberg JW
    J Clin Oncol; 2012 Oct; 30(28):3439-43. PubMed ID: 22949152
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical features and treatment outcomes of intravascular large B-cell lymphoma: a single-center experience in Korea.
    Hong JY; Kim HJ; Ko YH; Choi JY; Jung CW; Kim SJ; Kim WS
    Acta Haematol; 2014; 131(1):18-27. PubMed ID: 24021554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.